These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19894272)

  • 21. Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology.
    Dreu R; Sirca J; Pintye-Hodi K; Burjan T; Planinsek O; Srcic S
    Int J Pharm; 2005 Mar; 291(1-2):99-111. PubMed ID: 15707736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F; Knight PE; Newton JM
    Int J Pharm; 2008 Feb; 350(1-2):145-54. PubMed ID: 17905548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of formulations for the preparation of new formula pellets.
    Gajdziok J; Bernatoniene J; Muselík J; Masteiková R; Dvořáčková K; Petkeviciute Z; Lazauskas R; Kalveniene Z; Bernatoniene R
    Pharm Dev Technol; 2011 Oct; 16(5):520-8. PubMed ID: 20649408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y; Shi CY; Fang JG; Wang WQ
    Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV; Gu L; Soh JL; Heng PW
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drying behaviour of two sets of microcrystalline cellulose pellets.
    Berggren J; Alderborn G
    Int J Pharm; 2001 May; 219(1-2):113-26. PubMed ID: 11337172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization.
    Souto C; Rodríguez A; Parajes S; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):94-9. PubMed ID: 15967651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use.
    Hoang Thi TH; Lhafidi S; Carneiro SP; Flament MP
    Int J Pharm; 2015 Dec; 496(2):842-9. PubMed ID: 26403385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets.
    Almeida Prieto S; Blanco Méndez J; Otero Espinar FJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):511-21. PubMed ID: 15760732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
    Kleinebudde P; Schröder M; Schultz P; Müller BW; Waaler T; Nymo L
    Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of inert cushioning beads: effect of excipients on the physicomechanical properties of freeze-dried beads containing microcrystalline cellulose produced by extrusion-spheronization.
    Habib YS; Augsburger LL; Shangraw RF
    Int J Pharm; 2002 Feb; 233(1-2):67-83. PubMed ID: 11897412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preparation of pellets containing non-ionic surfactants by extrusion/spheronization.
    Podczeck F; Alessi P; Newton JM
    Int J Pharm; 2008 Sep; 361(1-2):33-40. PubMed ID: 18571347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.
    Basit AW; Newton JM; Lacey LF
    Pharm Dev Technol; 1999; 4(4):499-505. PubMed ID: 10578503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of drying technique on extrusion-spheronisation granules and tablet properties.
    Song B; Rough SL; Wilson DI
    Int J Pharm; 2007 Mar; 332(1-2):38-44. PubMed ID: 17071030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the tabletting behaviour of microcrystalline cellulose pellets by the incorporation of polyethylene glycol.
    Nicklasson F; Alderborn G
    Eur J Pharm Sci; 1999 Oct; 9(1):57-65. PubMed ID: 10493997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.